Aimed Bio Inc (0009K0) Stock Price & News

Why is 0009K0 up 2.40%?

Dive Deeper

0009K0:KOSDAQ

Aimed Bio Inc

₩18,800.00

+2.40%

(+440.00) 1D

Nov 4, 3:30:11 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 0009K0...

Open

₩18,390

High

₩18,800

Low

₩17,390

Mkt. cap

1.22T

Avg. vol.

137.79K

Volume

194.45K

P/E ratio

23.27

52-wk high

₩80,200

52-wk low

₩17,390

EPS

₩808

Shares outstanding

65.14M

Open

₩18,390

High

₩18,800

Low

₩17,390

Mkt. cap

1.22T

Avg. vol.

137.79K

Volume

194.45K

P/E ratio

23.27

52-wk high

₩80,200

52-wk low

₩17,390

EPS

₩808

Shares outstanding

65.14M

Related stocks

Dong-A Socio Holdings Co Ltd

₩88,000.00

+1.15%

000250

Sam Chun Dang Pharm Co Ltd

News stories

From web sources and news partners

FinancialContent

25 minutes ago

U.S. Physical Therapy (NYSE:USPH) reports strong Q3 2026

MarketWatch

1 hour ago

Dow scores its best day in 18 months in a broad relief rally after Democrats sweep to power in Congress

shattered.io

32 minutes ago

S&P Earnings Jump 30.2% as Big Tech Cash Flow Sinks [2026]

PBS

1 hour ago

U.S. stocks surge, and the Dow soars 1,500 points as Brent oil's price drops below $95 per barrel

About Aimed Bio Inc

CEO-

Employees-

Founded2018

Headquarters-

SectorBiotechnology

Industry-

Websiteaimedbio.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	114.24M	37.98B	8.50B	20.20B
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-904.24M	1.19B	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.98B	13.00B	10.37B	11.68B
Operating expense	5.98B	12.46B	12.46B	11.68B
Total operating expenses	5.98B	12.46B	12.46B	11.68B
Operating income	-5.87B	25.52B	-3.96B	8.52B
Other non operating income	665.52M	5.60M	-1.40B	1.33B
EBT including unusual items	-5.20B	25.74B	-2.01B	9.85B
EBT excluding unusual items	-5.20B	25.76B	-779.96M	9.85B
Income tax expense	-	-9.18B	-	-1.03B
Effective tax rate	-	-35.67%	-	-10.44%
Other operating expenses	-	-	-	-
Net income	-5.20B	34.92B	-2.01B	10.88B
Net profit margin	-4,549.74%	91.95%	-23.66%	53.89%
Earnings per share	-	-	-	-
Interest and investment income	-	673.31M	2.54B	-
Interest expense	-	-23.82M	-105.22M	-
Net interest expenses	-	649.49M	2.44B	-
Depreciation and amortization charges	-	284.77M	745.13M	-
EBITDA	-5.52B	25.88B	-3.53B	8.99B
Gain or loss from assets sale	-	16.22M	-	4.08M

Finance

Ask anything